BioCardia CEO Peter Altman acquires common shares worth $3,749.80

BCDA•2026-07-15

Insider share purchases

BioCardia President, CEO and director Peter Altman bought 4,300 common shares in open-market purchases at weighted-average prices of $0.88 and $0.86.

Altman’s direct holding rose to 368,385 common shares.

Sources

BioCardia CEO Peter Altman acquires common shares worth $3,749.80

Sec

BioCardia CEO Peter Altman acquires common shares worth $3,749.80

Insider share purchases

Related News

SBA Communications launches USD 3.5 billion senior notes offering across three tranches

Crescent Biopharma launches underwritten public offering of ordinary shares, pre-funded warrants

Yorkville Acquisition amends sponsor working-capital note to $500,000

Sources

BioCardia CEO Peter Altman acquires common shares worth $3,749.80

Power Integrations to release Q2 results, host conference call

AST Spacemobile Announces Proposed Private Offering Of $1 Billion Of Convertible Senior Notes Due 2034